Sanofi Aventis

Fasturtec-rasburnat

"Fasturtec" contains Molecule / Drug called “Rasburicase”. Fasturtec is a urate-oxidase enzyme. When chemotherapy is given, cancer cells are destroyed, releasing large amounts of uric acid into the blood. Rasburicase works by allowing uric acid to be more easily removed from the body by the kidneys.

“Rasburnat” is the generic version of “Fasturtec” and both contains same drug “Rasburicase”.

Details
Specification

Indication

Fasturtec is used for preventing high blood levels of uric acid from occurring in patients with certain types of cancer (eg, leukemia, lymphoma, solid malignant tumors) who are receiving cancer chemotherapy treatment.

Note

Precaution

Fasturtec is a prescription drug and should be used under proper medical guidance and advice.

Fasturtec can cause severe hypersensitivity reactions including anaphylaxis.

Updated On Nov 02, 2019 by Admin

Strength

1.5 mg

Packing

Vial

Storage

Store at 2 - 8°C

Was this page helpful?

☆ ☆ ☆ ☆ ☆

Not Upto Date Insufficient Helpful

Any suggestions or inputs for Shubhampharma.

Fasturtec-rasburnat also available as

NATCO PHARMA LIMITED (INDIA)

Rasburnat

RASBURNAT contains Drug / Molecule called “Rasburicase". Rasburicase is a urate-oxidase enzyme. When chemotherapy is given, cancer cells are destroyed, releasing large amounts of uric acid into the blood. Rasburicase works by allowing uric acid to be more easily removed from the body by the kidneys.